Inventor
HSU MING-CHU
TW17 patents
⚠️ This page may combine multiple inventors who share the name “HSU MING-CHU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
5 patentsUS5070010ADec 3, 1991
Method for determining anti-viral transactivating activity
HOFFMANN LA ROCHE76 citations95
US5041438AAug 20, 1991
Method for treating retroviral infections with benzodiazepine compounds
HOFFMANN LA ROCHE57 citations95
US5141735AAug 25, 1992
Substituted amino-benzodiazepines having anitviral activity
HOFFMANN LA ROCHE19 citations77
US5164376ANov 17, 1992
Method for treating retroviral infections with aryl-(2-pyrryl) keytone compound
HOFFMANN LA ROCHE10 citations72
US5036101AJul 30, 1991
Method for treating retroviral infections with aryl-(2-pyrryl) ketone compound
HOFFMANN LA ROCHE10 citations72
TAIGEN BIOTECHNOLOGY CO LTD
5 patentsUS10004719B1Jun 26, 2018
Solid dispersion formulation
TAIGEN BIOTECHNOLOGY CO LTD12 citations83
US10596171B2Mar 24, 2020
Cap-dependent endonuclease inhibitors
TAIGEN BIOTECHNOLOGY CO LTD2 citations68
US7462594B2Dec 9, 2008
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
TAIGEN BIOTECHNOLOGY CO LTD2 citations57
US9375406B2Jun 28, 2016
Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptor
TAIGEN BIOTECHNOLOGY CO LTD1 citations50
US10377714B2Aug 13, 2019
Trans-isomeric heterocyclic compounds and preparation thereof
TAIGEN BIOTECHNOLOGY CO LTD0 citations48
NAT HEALTH RESEARCH INSTITUTES
4 patentsUS6903104B2Jun 7, 2005
Indol-3-YL-2-oxoacetamide compounds and methods of use thereof
NAT HEALTH RESEARCH INSTITUTES15 citations91
US6706739B2Mar 16, 2004
Imidazolidinone compounds
NAT HEALTH RESEARCH INSTITUTES15 citations82
US7396838B2Jul 8, 2008
Use of 1H-indol-3-yl-2-oxoacetamide compounds
NAT HEALTH RESEARCH INSTITUTES2 citations61
US7662834B2Feb 16, 2010
Methods of 1H-indol-3-yl-2-oxoacetamide compounds
NAT HEALTH RESEARCH INSTITUTES0 citations50